{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:41:58Z","timestamp":1780695718618,"version":"3.54.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107364","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:58:39Z","timestamp":1724385519000},"page":"107364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics"],"prefix":"10.1016","volume":"208","author":[{"given":"Yuemiao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahan","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangjiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"A. Jemal, Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"20","key":"10.1016\/j.phrs.2024.107364_bib2","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3748\/wjg.v27.i20.2507","article-title":"RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets","volume":"27","author":"Chen","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","article-title":"Hepatocellular carcinoma","volume":"7","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.phrs.2024.107364_bib4","article-title":"Hepatocellular Carcinoma in 2021: An Exhaustive Update","volume":"13","author":"Philips","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/liv.15466","article-title":"Association of gut microbiome and primary liver cancer: A two-sample Mendelian randomization and case-control study","volume":"43","author":"Ma","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ydbio.2016.06.039","article-title":"Organoids from adult liver and pancreas: Stem cell biology and biomedical utility","volume":"420","author":"Hindley","year":"2016","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib7","first-page":"2962","article-title":"Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer","volume":"14","author":"Li","year":"2022","journal-title":"Am. J. Transl. Res"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","article-title":"Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism","volume":"3","author":"Elia","year":"2021","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.15430\/JCP.2020.25.3.164","article-title":"Gallstones, Cholecystectomy and the Risk of Hepatobiliary and Pancreatic Cancer: A Nationwide Population-based Cohort Study in Korea","volume":"25","author":"Huang","year":"2020","journal-title":"J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.phrs.2024.107364_bib11","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.3390\/cancers15123092","article-title":"Population-attributable fractions of personal comorbidities for liver, gallbladder, and bile duct cancers","volume":"15","author":"Hemminki","year":"2023","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.phrs.2024.107364_bib12","doi-asserted-by":"crossref","first-page":"2207366","DOI":"10.1002\/advs.202207366","article-title":"A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"issue":"7867","key":"10.1016\/j.phrs.2024.107364_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-021-03707-9","article-title":"A metabolomics pipeline for the mechanistic interrogation of the gut microbiome","volume":"595","author":"Han","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijmm.2016.03.006","article-title":"Challenges of metabolomics in human gut microbiota research","volume":"306","author":"Smirnov","year":"2016","journal-title":"Int J. Med Microbiol"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13073-020-00796-5","article-title":"Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107364_bib18","doi-asserted-by":"crossref","first-page":"1288525","DOI":"10.3389\/fmicb.2023.1288525","article-title":"Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Microbiol"},{"issue":"21","key":"10.1016\/j.phrs.2024.107364_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215379","article-title":"Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer","volume":"14","author":"Ito","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2024.107364_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.872019","article-title":"Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics","volume":"12","author":"Yang","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1186\/s12885-023-11493-y","article-title":"Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study","volume":"23","author":"Jiang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12866-022-02557-3","article-title":"Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis","volume":"22","author":"Kirishima","year":"2022","journal-title":"BMC Microbiol"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"F. B\u00e4ckhed, Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib25","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1080\/21655979.2022.2045823","article-title":"A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer","volume":"13","author":"Zhu","year":"2022","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"E. Mik\u00f3, The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.phrs.2024.107364_bib27","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/hep4.2003","article-title":"A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer","volume":"6","author":"Farhat","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3835(91)90209-Z","article-title":"Comparison of liver cancer and nodules induced in rats by deoxycholic acid diet with or without prior initiation","volume":"57","author":"Armstrong","year":"1991","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2024.107364_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/1574892814666191016162346","article-title":"Mechanism of a novel camptothecin-deoxycholic acid derivate induced apoptosis against human liver cancer HepG2 cells and human colon cancer HCT116 cells","volume":"14","author":"Xiao","year":"2019","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"12","key":"10.1016\/j.phrs.2024.107364_bib30","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00432-020-03374-9","article-title":"Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma","volume":"146","author":"Nguyen","year":"2020","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"26","key":"10.1016\/j.phrs.2024.107364_bib31","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1038\/s41388-020-1349-6","article-title":"Deoxycholic acid modulates the progression of gallbladder cancer through N(6)-methyladenosine-dependent microRNA maturation","volume":"39","author":"Lin","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s11671-018-2653-8","article-title":"The apoptosis effect on liver cancer cells of gold nanoparticles modified with lithocholic acid","volume":"13","author":"Zhao","year":"2018","journal-title":"Nanoscale Res Lett."},{"key":"10.1016\/j.phrs.2024.107364_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122355","article-title":"Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury","volume":"337","author":"Lu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107364_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115253","article-title":"Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism","volume":"205","author":"Li","year":"2022","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib35","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1038\/s41598-019-43502-1","article-title":"L. Kap\u00e1s, Butyrate, a metabolite of intestinal bacteria, enhances sleep","volume":"9","author":"Szentirmai","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107364_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","article-title":"Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis","volume":"164","author":"Sivaprakasam","year":"2016","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107364_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108273","article-title":"Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases","volume":"239","author":"Ikeda","year":"2022","journal-title":"Pharm. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2024.107364_bib38","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajpath.2023.06.007","article-title":"The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases","volume":"193","author":"Pant","year":"2023","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107364_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104952","article-title":"Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid","volume":"100","author":"Lau","year":"2024","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib41","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/hep.32080","article-title":"Histone deacetylase sirtuin 1 promotes loss of primary cilia in cholangiocarcinoma","volume":"74","author":"Pant","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107364_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107364_bib43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ejca.2004.01.039","article-title":"Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria\/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL","volume":"40","author":"Emanuele","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107364_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2017.06.001","article-title":"Oxidative stress plays a key role in butyrate-mediated autophagy via Akt\/mTOR pathway in hepatoma cells","volume":"273","author":"Pant","year":"2017","journal-title":"Chem. Biol. Inter."},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2003.09.021","article-title":"Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells","volume":"40","author":"Ogawa","year":"2004","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib46","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s13402-023-00831-8","article-title":"Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma","volume":"46","author":"Yang","year":"2023","journal-title":"Cell Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2024.107364_bib47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/carcin\/bgab039","article-title":"Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis","volume":"42","author":"Festa Ortega","year":"2021","journal-title":"Carcinogenesis"},{"issue":"27","key":"10.1016\/j.phrs.2024.107364_bib48","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1021\/acs.jafc.3c02499","article-title":"Sodium butyrate ameliorates deoxynivalenol-induced oxidative stress and inflammation in the porcine liver via nr4a2-mediated histone acetylation","volume":"71","author":"Zong","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"10.1016\/j.phrs.2024.107364_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med"},{"issue":"7947","key":"10.1016\/j.phrs.2024.107364_bib50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41586-022-05645-6","article-title":"Tissue CD14(+)CD8(+) T cells reprogrammed by myeloid cells and modulated by LPS","volume":"614","author":"Pallett","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107364_bib51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1741-7015-10-98","article-title":"Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide","volume":"10","author":"Jing","year":"2012","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.phrs.2024.107364_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29683","article-title":"Lipopolysaccharide promotes cancer cell migration and invasion through METTL3\/PI3K\/AKT signaling in human cholangiocarcinoma","volume":"10","author":"Ke","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.phrs.2024.107364_bib53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPA.0000000000001790","article-title":"Direct Effects of Lipopolysaccharide on Human Pancreatic Cancer Cells","volume":"50","author":"Massoumi","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.phrs.2024.107364_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2020.11.588","article-title":"PD-L1 induced by lipopolysaccharide via TLR4\/MyD88\/NF-\u03baB pathway promotes immune escape in pancreatic cancer","volume":"23","author":"Wu","year":"2021","journal-title":"HPB"},{"issue":"18","key":"10.1016\/j.phrs.2024.107364_bib55","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1021\/acs.nanolett.3c02728","article-title":"Targeting pyroptosis through lipopolysaccharide-triggered noncanonical pathway for safe and efficient cancer immunotherapy","volume":"23","author":"Chen","year":"2023","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12944-019-1017-4","article-title":"Lipopolysaccharide and palmitic acid synergistically induced MCP-1 production via MAPK-meditated TLR4 signaling pathway in RAW264.7 cells","volume":"18","author":"Wang","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"8","key":"10.1016\/j.phrs.2024.107364_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082308","article-title":"A systematic review and meta-analysis: volatile organic compound analysis in the detection of hepatobiliary and pancreatic cancers","volume":"15","author":"Pelling","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/carcin\/bgz116","article-title":"Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer","volume":"41","author":"Mendez","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2024.107364_bib59","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15386","article-title":"(1)H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism","volume":"11","author":"Treeriya","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2024.107364_bib60","doi-asserted-by":"crossref","first-page":"1184869","DOI":"10.3389\/fmicb.2023.1184869","article-title":"Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.phrs.2024.107364_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2021-326710","article-title":"Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome","volume":"71","author":"Newsome","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107364_bib62","doi-asserted-by":"crossref","first-page":"1170748","DOI":"10.3389\/fcimb.2023.1170748","article-title":"Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients","volume":"13","author":"Li","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"issue":"4","key":"10.1016\/j.phrs.2024.107364_bib63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00203-024-03914-8","article-title":"Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer","volume":"206","author":"Elango","year":"2024","journal-title":"Arch. Microbiol"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-015-1631-9","article-title":"Clinical sequencing: is WGS the better WES?","volume":"135","author":"Meienberg","year":"2016","journal-title":"Hum. Genet"},{"issue":"7","key":"10.1016\/j.phrs.2024.107364_bib65","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.phrs.2024.107364_bib66","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1007\/s00432-023-04716-z","article-title":"Low-coverage and cost-effective whole-genome sequencing assay for glioma risk stratification","volume":"149","author":"Qin","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107364_bib67","doi-asserted-by":"crossref","first-page":"16585","DOI":"10.1021\/acsomega.8b01761","article-title":"Impact of Sample Storage on the NMR Fecal Water Metabolome","volume":"3","author":"O'Sullivan","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.phrs.2024.107364_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.961448","article-title":"Pre-analytical processing of plasma and serum samples for combined proteome and metabolome analysis","volume":"9","author":"Gegner","year":"2022","journal-title":"Front Mol. Biosci."},{"issue":"20","key":"10.1016\/j.phrs.2024.107364_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204775","article-title":"Current status of matrix-assisted laser desorption\/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) in clinical diagnostic microbiology","volume":"25","author":"Tsuchida","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2019.01.001","article-title":"Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle","volume":"176","author":"Pasolli","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib71","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2022.09.024","article-title":"Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications","volume":"164","author":"Nagata","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib72","doi-asserted-by":"crossref","first-page":"2236364","DOI":"10.1080\/19490976.2023.2236364","article-title":"Colorectal cancer and gut microbiota studies in China","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107364_bib73","article-title":"Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics","volume":"11","author":"Yu","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib74","doi-asserted-by":"crossref","first-page":"2375483","DOI":"10.1080\/19490976.2024.2375483","article-title":"A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer","volume":"16","author":"Villani","year":"2024","journal-title":"Gut Microbes"},{"issue":"75","key":"10.1016\/j.phrs.2024.107364_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn0704","article-title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer","volume":"7","author":"Mirji","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2024.107364_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.924696","article-title":"Utilizing gut microbiota to improve hepatobiliary tumor treatments: recent advances","volume":"12","author":"Qin","year":"2022","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib77","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","article-title":"Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib78","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/j.gastro.2020.11.041","article-title":"Cancer and the microbiome-influence of the commensal microbiota on cancer, immune responses, and immunotherapy","volume":"160","author":"Matson","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2024.107364_bib79","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1080\/21645515.2017.1359362","article-title":"Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers","volume":"13","author":"Hochnadel","year":"2017","journal-title":"Hum. Vaccin Immunother."},{"issue":"14","key":"10.1016\/j.phrs.2024.107364_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143573","article-title":"Bile acids and microbiota interplay in pancreatic cancer","volume":"15","author":"Malhotra","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2024.107364_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.634874","article-title":"Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy","volume":"8","author":"Geng","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib82","doi-asserted-by":"crossref","first-page":"2320280","DOI":"10.1080\/19490976.2024.2320280","article-title":"Roles of microbiota in pancreatic cancer development and treatment","volume":"16","author":"Cruz","year":"2024","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.phrs.2024.107364_bib83","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab."},{"issue":"7950","key":"10.1016\/j.phrs.2024.107364_bib84","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41392-023-01506-4","article-title":"A metabolite of the gut microbiota: a facilitator of chemotherapy efficacy in cancer","volume":"8","author":"Kwon","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"15","key":"10.1016\/j.phrs.2024.107364_bib86","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"7","key":"10.1016\/j.phrs.2024.107364_bib87","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004147","article-title":"Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy","volume":"10","author":"Rangan","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"6_Supplement","key":"10.1016\/j.phrs.2024.107364_bib88","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-6690","article-title":"Gut microbial metabolite butyrate facilitates antitumor efficacy of telomerase-specific oncolytic adenovirus via MHC-I and cGAS-STING pathway activation","volume":"84","author":"Sakamoto","year":"2024","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.phrs.2024.107364_bib89","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1007\/s00432-022-04544-7","article-title":"Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma","volume":"149","author":"Kumar","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107364_bib90","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/jcmm.17322","article-title":"Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc\/hexokinase 2 pathway","volume":"26","author":"Yu","year":"2022","journal-title":"J. Cell Mol. Med"},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib91","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/toxsci\/kfac103","article-title":"Transcriptional regulation of human arylamine N-acetyltransferase 2 gene by glucose and insulin in liver cancer cell lines","volume":"190","author":"Hong","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/HEP.0000000000000047","article-title":"Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis","volume":"78","author":"Che","year":"2023","journal-title":"Hepatology"},{"issue":"6516","key":"10.1016\/j.phrs.2024.107364_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay9097","article-title":"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites","volume":"370","author":"Guo","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib94","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202993","article-title":"The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice","volume":"41","author":"Zhu","year":"2021","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib95","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jcp.30651","article-title":"Lactobacillus plantarum alleviates irradiation-induced intestinal injury by activation of FXR-FGF15 signaling in intestinal epithelia","volume":"237","author":"Jian","year":"2022","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib96","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gutjnl-2018-316226","article-title":"Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells","volume":"68","author":"Riehl","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib97","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-024-01285-9","article-title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events","volume":"16","author":"Hu","year":"2024","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib98","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12885-019-6150-y","article-title":"Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab","volume":"19","author":"Masuda","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032769","article-title":"Implication of the Gut microbiome and microbial-derived metabolites in immune-related adverse events: emergence of novel biomarkers for cancer immunotherapy","volume":"24","author":"Dora","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.phrs.2024.107364_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031544","article-title":"Bile acid diarrhea: from molecular mechanisms to clinical diagnosis and treatment in the era of precision medicine","volume":"25","author":"Yang","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cels.2020.02.008","article-title":"Gut-liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids","volume":"10","author":"Trapecar","year":"2020","journal-title":"Cell Syst."},{"issue":"2","key":"10.1016\/j.phrs.2024.107364_bib103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/nbu.12377","article-title":"Gut-derived short-chain fatty acids: A friend or foe for hepatic lipid metabolism?","volume":"44","author":"Chambers","year":"2019","journal-title":"Nutr. Bull."},{"issue":"3","key":"10.1016\/j.phrs.2024.107364_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031105","article-title":"Gut microbiota and short chain fatty acids: implications in glucose homeostasis","volume":"23","author":"Portincasa","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107364_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122304","article-title":"Review on chronic metabolic diseases surrounding bile acids and gut microbiota: what we have explored so far","volume":"336","author":"Zhu","year":"2024","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.phrs.2024.107364_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061406","article-title":"The role of the gut microbiome in colorectal cancer development and therapy response","volume":"12","author":"S\u00e1nchez-Alcoholado","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107364_bib107","doi-asserted-by":"crossref","first-page":"1114707","DOI":"10.3389\/fmicb.2023.1114707","article-title":"Biosensors for point-of-care testing and personalized monitoring of gastrointestinal microbiota","volume":"14","author":"Ngashangva","year":"2023","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.phrs.2024.107364_bib108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chom.2023.11.011","article-title":"Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma","volume":"32","author":"Yu","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.phrs.2024.107364_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108605","article-title":"Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches","volume":"256","author":"Williams","year":"2024","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107364_bib110","doi-asserted-by":"crossref","DOI":"10.2174\/0109298673274040231121113410","article-title":"Bile acid-conjugate as a promising anticancer agent: recent progress","author":"Rathod","year":"2024","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.phrs.2024.107364_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122047","article-title":"Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis","volume":"295","author":"Shashni","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107364_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120877","article-title":"Design of enzyme-responsive short-chain fatty acid-based self-assembling drug for alleviation of type 2 diabetes mellitus","volume":"275","author":"Shashni","year":"2021","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.phrs.2024.107364_bib113","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1208\/s12249-021-02124-5","article-title":"Lipopolysaccharide nanosystems for the enhancement of oral bioavailability","volume":"22","author":"Sumaila","year":"2021","journal-title":"AAPS PharmSciTech"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T23:11:57Z","timestamp":1726787517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":113,"alternative-id":["S1043661824003098"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107364","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the microbiota metabolome in hepatobiliary and pancreatic cancers: Pathways to precision diagnostics and targeted therapeutics","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107364"}}